C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 790.00
-9.00 (-1.13%)
At close: Apr 24, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 45.4 billion as of April 24, 2026. Its market cap has decreased by -20.83% in one year.
Market Cap
45.40B
Enterprise Value
41.18B
Revenue
64.98B
Ranking
n/a
PE Ratio
17.56
Stock Price
790.00
Market Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 3.81B to 45.40B, an increase of 1,091.64%. That is a compound annual growth rate of 76.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 45.40B | -12.22% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 2,744.60% |
| Dec 9, 2021 | 3.81B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 657.16B |
| DreamCIS | 123.38B |
| HLB bioStep | 107.65B |
| P&K Skin Research Center | 73.65B |
| WOOJUNG BIO | 52.68B |
| DT&CRO CO. | 44.55B |
| SLS BIO | 26.89B |
| BioInfra | 20.77B |